These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Clozapine--a new antipsychotic agent. Simpson GM; Varga E Curr Ther Res Clin Exp; 1974 Jul; 16(7):679-86. PubMed ID: 4210457 [No Abstract] [Full Text] [Related]
25. [Carpipramine as treatment of inhibition]. Fontan M; Goudemand M; Roeland P; Gamblin P Lille Med; 1979 Feb; 24(2):151-5. PubMed ID: 372716 [No Abstract] [Full Text] [Related]
26. [Therapeutic efficacy of tricyclic and antidepressive agents. Comparative double blind test of amitriptyline and mianserin (Org GB 94)]. Bohacek N; Mihovilović M; Bakran I Acta Med Iugosl; 1976; 30(5):425-40. PubMed ID: 1015345 [No Abstract] [Full Text] [Related]
27. [Comparative bioavailability of 3 oral forms of metapramine in healthy volunteers]. Bougerolle AM; Chabard JL; Dordain G; Gaillot J; Piron JJ; Berger JA Therapie; 1984; 39(6):619-24. PubMed ID: 6531734 [No Abstract] [Full Text] [Related]
28. [Clinical results with the use of melitracen in depressive syndromes]. Di Genio R; Marzo M Clin Ter; 1976 Apr; 77(2):171-81. PubMed ID: 795587 [No Abstract] [Full Text] [Related]
29. Psychopharmacologic drugs in the treatment of the irritable bowel syndrome. A double blind study of the effect of trimipramine. Myren J; Lövland B; Larssen SE; Larsen S Ann Gastroenterol Hepatol (Paris); 1984; 20(3):117-23. PubMed ID: 6529168 [TBL] [Abstract][Full Text] [Related]
30. [Results of using tricyclic antidepressive drugs in the treatment of endogenous depression (comparative analysis of 7 drugs)]. Beresewicz M; Bidzińska E; Koszewska I; Puzyński S Psychiatr Pol; 1991; 25(3-4):13-8. PubMed ID: 1687987 [TBL] [Abstract][Full Text] [Related]
31. Clozapine--a potential antipsychotic agent without extrapyramidal manifestations. Matz R; Rick W; Thompson H; Gershon S Curr Ther Res Clin Exp; 1974 Jul; 16(7):687-95. PubMed ID: 4210458 [No Abstract] [Full Text] [Related]
32. [Comparative effectiveness of tricyclic antidepressants in the treatment of psychic changes in ischemic heart disease]. Zaĭtsev VP; Kol'tsova TI Ter Arkh; 1980; 52(5):84-7. PubMed ID: 6996189 [No Abstract] [Full Text] [Related]
35. [Evaluation of the central anticholinergic activity of antidepressants. Comparison of two experimental methods]. Dufour P; Billa JP; Fabre J; Roquebert J Ann Pharm Fr; 1989; 47(3):135-41. PubMed ID: 2634929 [TBL] [Abstract][Full Text] [Related]
37. [Comparison of therapeutic effect of clozapin and chlorpromazin (author's transl)]. Vencovský E; Peterová E; Baudis P Cesk Psychiatr; 1975 Jan; 71(1):21-6. PubMed ID: 1093729 [No Abstract] [Full Text] [Related]
38. A new class of antiarrhythmic--defibrillatory compounds. Erez M; Varon D J Basic Clin Physiol Pharmacol; 1994; 5(1):59-66. PubMed ID: 8736071 [TBL] [Abstract][Full Text] [Related]
39. [Preliminary therapeutic results with a new benzodiazepine preparation: clozapine]. Failla E; Fiorillo A Acta Neurol (Napoli); 1976; 31(4):509-23. PubMed ID: 799902 [No Abstract] [Full Text] [Related]